Saudi Arabia vs Sur: Estimated antiretroviral therapy coverage among people living with HIV
Saudi Arabia
97.0%
in 2025
Sur
50.0%
in 2025
Saudi Arabia rank
2nd
Sur rank
1st
Estimated antiretroviral therapy coverage among people living with HIV over time
- Saudi Arabia
- Sur
How they compare
Saudi Arabia currently reports 97.0% against 50.0% in Sur, a difference of 47.0%.
That makes Saudi Arabia's figure about 1.9 times Sur's.
Across all 26 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 2nd and Sur ranks 1st of 143 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.2% | 7.3% | 28.9% | Saudi Arabia |
| 2010s | 50.3% | 33.4% | 16.9% | Saudi Arabia |
| 2020s | 86.2% | 46.7% | 39.5% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Saudi Arabia or Sur?
- Saudi Arabia, at 97.0% against 50.0% in Sur as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Saudi Arabia and Sur?
- 47.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Sur?
- 26 years are reported by both, from 2000 to 2025.
- How do Saudi Arabia and Sur rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Saudi Arabia ranks 2nd and Sur ranks 1st of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.